PLD3 antibody (AA 70-176)

Catalog No. ABIN7163337

Product Details anti-PLD3 Antibody

Target: PLD3 (Phospholipase D family member 3 (PLD3))

Binding Specificity: AA 70-176

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This PLD3 antibody is un-conjugated

Application: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Phospholipase D3 protein (70-176AA)

Isotype: IgG

Application Details

Application Notes: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for PLD3

Target: PLD3 (Phospholipase D family member 3 (PLD3))

Alternative Name: PLD3 (PLD3 Products)

Synonyms: DDBDRAFT_0204850 antibody, DDBDRAFT_0231505 antibody, DDB_0204850 antibody, DDB_0231505 antibody, DDBDRAFT_0187542 antibody, DDBDRAFT_0220113 antibody, DDB_0187542 antibody, DDB_0220113 antibody, HU-K4 antibody, HUK4 antibody, Sam-9 antibody, phospholipase D3 antibody, phospholipase D family member 3 antibody, phospholipase D family, member 3 antibody, CpipJ_CPIJ017227 antibody, pldZ antibody, pldY antibody, DICPUDRAFT_30308 antibody, PLD3 antibody, Pld3 antibody

Background:

Background: May be involved in APP processing.

Aliases: Choline phosphatase 3 antibody, HindIII K4L homolog antibody, HU K4 antibody, Hu-K4 antibody, HUK4 antibody, Phosphatidylcholine hydrolyzing phospholipase D3 antibody, Phosphatidylcholine-hydrolyzing phospholipase D3 antibody, Phospholipase D family, member 3 antibody, Phospholipase D3 antibody, PLD 3 antibody, PLD3 antibody, PLD3_HUMAN antibody

UniProt: Q8IV08

Pathways: SARS-CoV-2 Protein Interactome